| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-06 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-06 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.2 | 1e-05 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |